Investor Relations

Investor Relations

Company News, Updates and Press Releases

Investors2022-08-10T08:31:37-07:00

Building better oncology tools

Company Overview

AccuStem is a clinical stage diagnostics company dedicated to optimizing outcomes for all patients with cancer across the globe. The company takes a holistic view of its role in oncology- to empower patients and their care team with critical answers and tools and drive innovation in healthcare.

Our Technology

We are building an ecosystem of products that will change how cancer is treated and managed.

Find Out More
ACUT Chart by TradingView

Accustem Sciences, Inc (ACUT)

Accustem Sciences Inc started trading on the OTC under ACUT on March 2, 2022. For more investor information please contact us using our contact form or emailing us at [email protected]

View Current Stock Price
View Investor Report Page

Accustem Sciences, Inc (ACUT)

Accustem Sciences Inc started trading on the OTC under ACUT on March 2, 2022. For more investor information please contact us using our contact form or emailing us at [email protected]

View Current Stock Price
View Investor Report Page

Interim Reports

View All

Annual Reports

View All

Annual General Meeting

View All

Latest news

Read all articles

Information For Shareholders Regarding Accustem Shares

Holders of record of shares of Accustem Sciences Inc should refer to the below instructions regarding the process to receive their shares. Please contact Philadelphia Stock Transfer (“PST”) with any questions regarding the process.

If you wish to transfer your shares to a U.S. bank or broker, follow the steps below:

  1. Send a copy of your DRS Statement to your broker.
  2. Your broker will set up what is known as a “DRS Profile” to sweep the shares from PST’s database based on the information in the DRS Statement.  
  3. Provided the request matches the information on PST’s database, the shares will transfer from PST to your broker.
  4. Your broker will internally allocate the shares to your personal account at that broker.

If you wish to transfer your shares to a non-U.S. bank or broker, follow the steps below:

  1. Send a copy of your DRS statement to your local broker and advise them that they need to set up a “DRS Profile” (and no other type of trade) to “pull” the shares from PST in the United States. This is a technical process but given the international nature of securities markets, your broker’s settlement agent will understand the required process.
  2. The local broker then must interact with their operations team to properly instruct their U.S. clearing agent to set up a DRS Profile request on their behalf based on the information in the DRS Statement.
    Note: The local broker should refer to their U.S. clearing agent for any guidance if they are not clear on the appropriate format of the instruction, as this part of the process is an internal matter.
  3. The U.S. clearing agent will set up a DRS Profile to “pull” your shares from PST’s database based on the information in the DRS Statement.
  4. Provided the request matches the information on PST’s database, the shares will transfer from PST to the U.S. clearing agent.
  5. The U.S. clearing agent will internally allocate your shares to the account of your local broker.
  6. Your local broker will internally allocate the shares to your personal account at your broker.

  1. Send a copy of the DRS Statement to your US clearing agent and advise them that a DRS Profile (and no other type of trade) should be set up to pull the shares from PST in the United States.
  2. You must interact internally with their operations team to properly instruct their U.S. clearing agent to set up a DRS Profile request on their behalf based on the information in the DRS Statement. This will generally include the customer registration name, PST account number, and total number of shares. You will need to communicate internally to their U.S. clearing agent for any guidance if they are not clear on the appropriate format of the instruction, as this part of the process is an internal matter.
  3. The U.S. clearing agent will set up a DRS Profile on behalf of the UK broker to sweep the shares from PST’s database based on the information in the DRS Statement.
  4. Provided the request matches the information on PST’s database, the shares will transfer from PST to the U.S. clearing agent.
  5. The U.S. clearing agent will internally allocate the shares to the account of their customer, the UK broker
  6. You will then internally allocate the shares at their firm to the custody positions of their underlying customers upon receipt of the shares.

If you have not received your DRS Statement and you are a certified shareholder or a broker/nominee, please contact us on [email protected] further assistance. Alternatively, you can contact Philadelphia Stock Transfer directly.

Accustem shares will not show up in your account unless the broker has taken the appropriate action via the DTCC Clearing system.

If your shares are not showing in your account with your broker, please contact your broker directly.

You, together with your broker, should contact Philadelphia Stock Transfer with any questions on transferring your shares. You can contact PST by:

Calling: +1 (866) 223-0448 (US, Canada, Puerto Rico) or +1 (484) 416-3124 (non-US);
Emailing: [email protected] or
Writing to: Philadelphia Stock Transfer, 2320 Haverford Road, Suite 230, Ardmore, PA 19003, USA

The website for PST is: www.philadelphiastocktransfer.com

Accustem Sciences, Inc
55 Park Lane
London, W1k 1NA

Useful Links

Stay Informed

Thank you for your message. It has been sent.

There was an error trying to send your message. Please try again later.

Accustem Sciences, Inc © 2022

Go to Top